14522-07-7

Basic information

• Product Name: N-[2-(3,4-dihydroxyphenyl)-2-oxo-ethyl]acetamide
• Synonyms: N-[2-(3,4-dihydroxyphenyl)-2-oxo-ethyl]acetamide;N-acetylarterenone
• CAS NO: 14522-07-7
• Molecular Formula: C₁₀H₁₁NO₄
• Molecular Weight: 209.2
• Mol File: 14522-07-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 570.3°Cat760mmHg
• Flash Point: 298.7°C
• Appearance: /
• Density: 1.334g/cm³
• Vapor Pressure: 1.31E-13mmHg at 25°C
• Refractive Index: 1.59
• PKA: 7.80±0.20(Predicted)
• CAS DataBase Reference: N-[2-(3,4-dihydroxyphenyl)-2-oxo-ethyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-(3,4-dihydroxyphenyl)-2-oxo-ethyl]acetamide(14522-07-7)
• EPA Substance Registry System: N-[2-(3,4-dihydroxyphenyl)-2-oxo-ethyl]acetamide(14522-07-7)

Safety Data

• Hazardous Substances Data: 14522-07-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H11NO4/c1-6(12)11-5-10(15)7-2-3-8(13)9(14)4-7/h2-4,13-14H,5H2,1H3,(H,11,12)

Upstream product

• 2494-12-4 N-acetyldopamine 
• 76734-99-1 2-(3',4'-dihydroxyphenyl)-3-acetylamino-6-(N-acetyl-2''-aminoethyl)-2,3-dihydro-1,4-benzodioxin 
• 499-61-6 arterenone 
• 108-24-7 acetic anhydride 

Downstream Products

• 795301-17-6 N-[2-(3,4-dihydroxy-phenyl)-1-hydroxymethyl-2-oxo-ethyl]-acetamide 

Relevant articles and documents

Process for producing threo-3-amino-2-hydroxybutanoyl-aminoacetic acids, as well as novel intermediated therefor and process for producing them

A process for producing threo-3-amino-2-hydroxybutanoylaminoacetic acids comprises the steps of allowing to react a starting compound represented by the general formula: STR1 wherein R1 represents a naphthyl or a group of the formula: STR2 in which R6 and R7 represent individually hydrogen, halogen, amino or a protected amino, hydroxy or a protected hydroxy, a lower alkoxy or a lower alkyl and R2 represents a protected amino, with a starting compound represented by the general formula: STR3 wherein R3 represents hydrogen or an ester residue, to obtain threo-3-protected amino-2-hydroxy-4-oxobutanoic acid or its ester represented by the general formula: STR4 wherein R1, R2 and R3 have the same meanings as above, and then reducing the same into threo-3-protected amino-2-hydroxybutanoic acid or its ester represented by the general formula: STR5 wherein R1, R2 and R3 have the same meanings as above, and further converting the above compound into 3-amino-2-hydroxybutanoic acid represented by the general formula: STR6 wherein R2 ' represents amino or a protected amino, thereafter condensing the same, in a conventional manner for forming a peptide coupling, with a compound represented by the general formula: STR7 wherein R4 represents an alkyl having 3-4 carbon atom or 3-guanidinopropyl, while previously protecting as required those groups not relevant to the reaction, and removing the protecting groups for the functional groups to produce threo-3-amino-2-hydroxybutanoylaminoacetic acids represented by the general formula: STR8 wherein R1 and R4 have the same meanings as above. This invention also provides the compounds represented by the general formula (III) as novel intermediates for the above aimed compounds and a process for producing the intermediates.